The advisory from the New York State Department of Health was prompted by a rise in ciprofloxacin-resistant strains of Neisseria meningitidis.
Vaccines may be the best option to combat the increasing incidence of gonorrhea, including drug-resistant forms.
Gavi's expanded vaccine portfolio fits its goal of ensuring that lower-income countries have access to key vaccines as soon as possible.
The CDC's alerts detail recent travel-related cases and urge vaccination for those traveling to Saudi Arabia for the upcoming Hajj or Umrah pilgrimages.
Nearly all cases are in patients who performed the Umrah pilgrimage while in Saudi Arabia, and most infections are due to serogroup W.
Most of the cases involve the ST 1466 strain, which is disproportionately affecting adults ages 30 to 60, Black or African American people, and those with HIV.
The highest absolute risk of disabilities among adult meningitis survivors was for behavioral and emotional disorders, hearing loss, and impaired vision.
The FDA last week approved Pfizer's new vaccine, called Penbraya, which covers five serogroups.
Cases have been reported from three parts of the state, mainly involving Black adults who haven't received the MenACWY vaccine.
The vaccine targets outer membrane vesicles that are common to both Neisseria meningitidis and Neisseria gonorrhoeae.
